Advertisement

Genetics of asthma severity

  • Ladina Joos
  • Peter D. Paré
  • Andrew J. Sandford
Chapter
  • 76 Downloads
Part of the Progress in Inflammation Research book series (PIR)

Abstract

There is strong evidence for a major hereditary contribution to the etiology of asthma and allergic diseases. However, only a few epidemiological studies have specifically addressed the genetic contribution to asthma severity. Sarafino et al. studied 39 monozygotic twin pairs and 55 same-sex dizygotic twin pairs who were between 2 and 20 years of age and had asthma present in at least one member of each pair [1]. In the 23 monozygotic and 13 dizygotic twins who were concordant for asthma, there was a significant correlation of asthma severity, defined as the product of attack frequency and an intensity rating, for monozygotic pairs but not for dizygotic pairs. This difference between monozygotic and dizygotic severity correlation was significant. Wilson et al. studied factors relating to the severity of symptoms at 5 years of age in 51 children with a history of severe wheeze in early childhood [2]. A positive family history of asthma was the only significant predictor of overall severity, defined by severity of attacks and interval symptom score, suggesting a genetic predisposition.

Keywords

Asthma Severity Allergy Clin Immunol Respir Crit Human Airway Smooth Muscle Cell Angiotensin Converting Enzyme Polymorphism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sarafino EP, Goldfedder J (1995) Genetic factors in the presence, severity, and triggers of asthma. Arch Dis Child 73: 112–116PubMedCrossRefGoogle Scholar
  2. 2.
    Wilson NM, Dore CJ, Silverman M (1997) Factors relating to the severity of symptoms at 5 yrs in children with severe wheeze in the first 2 yrs of life. Eur Respir J 10: 346–353PubMedCrossRefGoogle Scholar
  3. 3.
    Aas K (1981) Heterogeneity of bronchial asthma. Sub-populations — or different stages of the disease. Allergy 36: 3–14PubMedCrossRefGoogle Scholar
  4. 4.
    Expert Panel Report II (1997) Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program, National Institutes of Health, Bethesda, MD, NIH publication: 97–4051Google Scholar
  5. 5.
    Osborne ML, Vollmer WM, Pedula KL, Wilkins J, Buist AS, M OH (1999) Lack of correlation of symptoms with specialist-assessed long-term asthma severity. Chest 115: 85–91PubMedCrossRefGoogle Scholar
  6. 6.
    Colice GL, Vanden Burgt J, Song J, Stampone P, Thompson PJ (1999) Categorizing asth-ma severity. Am J Resp Crit Care Med 160: 1962–1967PubMedCrossRefGoogle Scholar
  7. 7.
    Cockcroft DW, Swystun VA (1996) Asthma control versus asthma severity. J Allergy Clin Immunol 98: 1016–1018PubMedCrossRefGoogle Scholar
  8. 8.
    Redier H, Daures JP, Michel C, Proudhon H, Vervloet D, Charpin D, Marsac J, Dusser D, Brambilla C, Wallaert B et al (1995) Assessment of the severity of asthma by an expert system. Description and evaluation. Am J Respir Crit Care Med 151: 345–352PubMedCrossRefGoogle Scholar
  9. 9.
    Romeo G, McKusick VA (1994) Phenotypic diversity, allelic series and modifier genes [news]. Nat Genet 7: 451–453PubMedCrossRefGoogle Scholar
  10. 10.
    Rosenstein BJ (1994) Genotype-phenotype correlations in cystic fibrosis. Lancet 343: 746–747PubMedCrossRefGoogle Scholar
  11. 11.
    Liechti-Gallati S, Bonsall I, Malik N, Schneider V, Kraemer LG, Ruedeberg A, Moser H, Kraemer R (1992) Genotype/phenotype association in cystic fibrosis: analyses of the delta F508, R553X, and 3905insT mutations. Pediatr Res 32: 175–178PubMedCrossRefGoogle Scholar
  12. 12.
    Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, Meyers DA, Levitt RC (1995) Genetic susceptibility to asthma — bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 333: 894–900PubMedCrossRefGoogle Scholar
  13. 13.
    Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264: 1152–1156Google Scholar
  14. 14.
    Bonnefoy JY, Gauchat JF, Lecoanet-Henchoz S, Graber P, Aubry JP (1996) Regulation of human IgE synthesis. Ann NY Acad Sci 796: 59–71PubMedCrossRefGoogle Scholar
  15. 15.
    Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248PubMedCrossRefGoogle Scholar
  16. 16.
    Burchard EG, Silverman EK, Rosenwasser LJ, Borish L, Yandava C, Pillari A, Weiss ST, Hasday J, Lilly CM, Ford JG et al (1999) Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med 160: 919–922PubMedCrossRefGoogle Scholar
  17. 17.
    Chouchane L, Sfar I, Bousaffara R, El Kamel A, Sfar MT, Ismail A (1999) A repeat polymorphism in interleukin-4 gene is highly associated with specific clinical phenotypes of asthma. Int Arch Allergy Immunol 120: 50–55PubMedCrossRefGoogle Scholar
  18. 18.
    Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337: 1720–1725PubMedCrossRefGoogle Scholar
  19. 19.
    Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Hershey GKK (1999) The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol 104: 1008–1014PubMedCrossRefGoogle Scholar
  20. 20.
    Reihsaus E, Innis M, Maclntyre N, Liggett SB (1993) Mutations in the gene encoding for the 132-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8: 334–339PubMedCrossRefGoogle Scholar
  21. 21.
    Green SA, Turki J, Bejarano P, Hall IP, Liggett SB (1995) Influence of J32-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 13: 25–33PubMedCrossRefGoogle Scholar
  22. 22.
    Turki J, Pak J, Green SA, Martin RJ, Liggett SB (1995) Genetic polymorphisms of the (32-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that G1y16 correlates with the nocturnal phenotype. J Clin Invest 95: 1635–1641PubMedCrossRefGoogle Scholar
  23. 23.
    Hall IP, Wheatley A, Wilding P, Liggett SB (1995) Association of Glu 27 (32-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345: 1213–1214PubMedCrossRefGoogle Scholar
  24. 24.
    Ramsay CE, Hayden CM, Tiller KJ, Burton PR, Goldblatt J, Lesouef PN (1999) Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 29: 1195–1203PubMedCrossRefGoogle Scholar
  25. 25.
    Weir TD, Mallek N, Sandford AJ, Bai TR, Awadh N, FitzGerald JM, Cockcroft D, James A, Liggett SB, Paré PD (1998) (32-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 158: 787–791Google Scholar
  26. 26.
    Laurell CC, Eriksson S (1963) The electrophorectic al-globulin pattern of serum in a1antitrypsin deficiency. Scand J Clin Lab Invest 15: 132–140Google Scholar
  27. 27.
    Buist AS, Sexton GJ, Azzam AM, Adams BE (1979) Pulmonary function in heterozygotes for al-antitrypsin deficiency: a case-control study. Am Rev Respir Dis 120: 759–766Google Scholar
  28. 28.
    Hoffmann JJ, Kramps JA, Dijkman JH (1981) Intermediate al-antitrypsin deficiency in atopic allergy. Clin Allergy 11: 555–560PubMedCrossRefGoogle Scholar
  29. 29.
    Welch MH, Reinecke ME, Hammarsten JF, Guenter CA (1969) Antitrypsin deficiency in pulmonary disease: the significance of intermediate levels. Ann Intern Med 71: 533–542Google Scholar
  30. 30.
    Webb DR, Hyde RW, Schwartz RH, Hall WJ, Condemi JJ, Townes PL (1973) Serum a1antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis 108: 918–925PubMedGoogle Scholar
  31. 31.
    Katz RM, Lieberman J, Siegel SC (1976) al antitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. J Allergy Clin Immunol 57: 41–45Google Scholar
  32. 32.
    Lindmark B, Svenonius E, Eriksson S (1990) Heterozygous a1-antichymotrypsin and PiZ a1-antitrypsin deficiency. Prevalence and clinical spectrum in asthmatic children. Allergy 45: 197–203PubMedCrossRefGoogle Scholar
  33. 33.
    Hyde JS, Werner P, Kumar CM, Moore BS (1979) Protease inhibitor variants in children and young adults with chronic asthma. Ann Allergy 43: 8–13PubMedGoogle Scholar
  34. 34.
    Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195–3199PubMedCrossRefGoogle Scholar
  35. 35.
    Moffatt MF, Cookson WOCM (1997) Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 6: 551–554PubMedCrossRefGoogle Scholar
  36. 36.
    Chagani T, Pare PD, Zhu S, Weir TD, Bai TR, Behbehani NA, Fitzgerald JM, Sandford AJ (1999) Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 160: 278–282PubMedCrossRefGoogle Scholar
  37. 37.
    Page CP (1988) The role of platelet-activating factor in asthma. J Allergy Clin Immunol 81: 144–152PubMedCrossRefGoogle Scholar
  38. 38.
    Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M (1988) Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest 82: 1983–1991PubMedCrossRefGoogle Scholar
  39. 39.
    Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T, Takamatsu S, Zimmerman GA, McIntyre TM et al (1996) Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 97: 2784–2791PubMedCrossRefGoogle Scholar
  40. 40.
    Stafforini DM, Numao T, Tsodikov A, Vaitkus D, Fukuda T, Watanabe N, Fueki N, McIntyre TM, Zimmerman GA, Makino S et al (1999) Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 103: 989–997PubMedCrossRefGoogle Scholar
  41. 41.
    Hargreave FE, Dolovich J, Newhouse MT (1990) The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 85: 1098–1111PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2002

Authors and Affiliations

  • Ladina Joos
    • 1
  • Peter D. Paré
    • 1
  • Andrew J. Sandford
    • 1
  1. 1.McDonald Research Laboratories/iCAPTURE CentreUniversity of British Columbia St. Paul’s HospitalVancouverCanada

Personalised recommendations